Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Smoking Is Linked to Worse Outcomes in Patients With Systemic Sclerosis
Link ID 30636
Title Smoking Is Linked to Worse Outcomes in Patients With Systemic Sclerosis
Url http://www.medscape.com/viewarticle/732025?src=rss
Description Smoking cigarettes appears to have a deleterious effect on vascular, gastrointestinal, and respiratory outcomes in patients with systemic sclerosis (SSc), researchers reported online October 8th in Arthritis and Rheumatism. Reuters Health Information
Category Articles > Rheumatology
Keywords
Date Nov 9, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Cutaneous Neonatal Lupus Predicts Cardiac Lupus in Subsequent Child
  Cutaneous neonatal lupus in an older sibling is a risk factor for congenital heart block in later-born siblings, researchers report in the January 21st online issue of Arthritis and Rheumatism. Reuters Health Information
Category:   Articles > Rheumatology


2. PCP Complication of Infliximab Treatment in RA Patients
  Pneumocystis jiroveci pneumonia (PCP) is a serious complication in patients with rheumatoid arthritis (RA) who are treated with infliximab, according to results of a study published in the March 15th issue of Arthritis and Rheumatism. Reuters Health Information
Category:   Articles > Rheumatology


3. Rheumatoid Arthritis and Risk for Cardiovascular Disease: A Population-Based Cohort Study
  Kevin D. Deane, MD, comments on a study that examined the risk for cardiovascular disease in patients newly diagnosed with rheumatoid arthritis.
Medscape Rheumatology
Category:   Articles > Rheumatology


4. DMARDs May Modify Diabetes Risk in RA or Psoriasis PatientsDMARDs May Modify Diabetes Risk in RA or
  Adjusted diabetes risk was lower in patients receiving a tumor necrosis factor inhibitor or hydroxychloroquine vs other nonbiologic disease-modifying antirheumatic drugs. br / iMedscape Medical News/i
Category:   Articles > Rheumatology


5. Pegloticase Improves Clinical Outcomes of Severe, Refractory Gout
  Pegloticase quickly lowers serum urate levels and relieves pain in a substantial proportion of patients with severe, treatment-refractory gout, according to phase III clinical trial results presented Sunday at the American College of Rheumatology Annual Scientific Meeting in San Francisco. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS